Experts Recommend Steps for Canada to Eliminate Cervical Cancer by 2040
Specialists urge Canada to enhance HPV vaccination and cervical screening to eliminate cervical cancer by 2040. Despite structured plans, progress is lagging, necessitating immediate federal action.
In a compelling new segment on CPAC's PrimeTime Politics, specialists have outlined key recommendations for Canada to eliminate cervical cancer as a public health concern by 2040. Despite the potential for wiping out this preventable disease, current progress is described as lagging, with urgent calls for national action coming forth.
Strategy Overview
The Action Plan for the Elimination of Cervical Cancer in Canada, 2020-2030 emphasizes three core areas:
-
HPV Vaccination: The goal is to achieve 90% vaccination coverage among children under 18 by 2025. Vaccination is projected to prevent over 90% of cervical cancer cases. HPV vaccines are freely available up to age 26 in some provinces like British Columbia and Alberta, though uptake varies across regions.
-
Cervical Screening: There is a call for regularity in screening practices starting at age 25 for anyone with a cervix who has been sexually active. The preferred method is HPV testing every five years with self-collection options to ensure equitable access. In areas where HPV tests are unavailable, Pap tests every three years are recommended.
-
Implementation Targets: The plan sets a target for rolling out HPV primary screening across all provinces and territories by 2035. This initiative aims to prioritize underserved populations, including First Nations, Inuit, and Métis communities, incorporating self-screening to support health equity and reconciliation.
Current Challenges and Advocacy
Despite these strategic initiatives, cervical cancer’s incidence rate remains above elimination thresholds, with more than 4 cases per 100,000 people reported. In 2025, nearly 430 deaths were attributed to cervical cancer in Canada.
Advocates from the Society of Gynecologic Oncology of Canada and the Women's Health Coalition have called for a standardized national women’s health framework to improve HPV access and vaccination rates urgently. These recommendations were highlighted as crucial during discussions on February 25, 2026.
Looking Forward
Canada finds itself at a "critical crossroads" in its public health strategy against cervical cancer. Compared to countries like Australia and Sweden, where significant progress has been made, Canada's rates indicate the need for accelerated efforts and cohesive policy implementation.
The update on national guidelines is anticipated but has not yet been released. For those seeking personalized advice on cervical cancer prevention, consulting with healthcare providers and provincial or territorial guidelines remains essential.